河南东吉高科有限公司
标准物质
| CNLM-554-H-0.5 | L-GLUTAMIC ACID | 0.5G |
| CNLM-554-H-1 | L-GLUTAMIC ACID | 1G |
| CNLM-561-H-0.05 | L-ISOLEUCINE | 0.05G |
| CNLM-561-H-0.1 | L-ISOLEUCINE | 0.1G |
| CNLM-561-H-0.25 | L-ISOLEUCINE | 0.25G |
| CNLM-575-H-0.1 | L-PHENYLALANINE | 0.1G |
| CNLM-575-H-0.1MG | L-PHENYLALANINE | 0.1MG |
| CNLM-575-H-0.25 | L-PHENYLALANINE | 0.25G |
| CNLM-575-H-0.5 | L-PHENYLALANINE | 0.5G |
| CNLM-575-H-1 | L-PHENYLALANINE | 1G |
| CNLM-587-0.1 | L-THREONINE | 0.1G |
| CNLM-587-0.25 | L-THREONINE | 0.25G |
| CNLM-587-0.5 | L-THREONINE | 0.5G |
| CNLM-6077-0.1 | L-TRYPTOPHAN-N-FMOC | 0.1G |
| CNLM-615-1 | L-LEUCINE | 1G |
| CNLM-615-95-1 | L-LEUCINE | 1G |
| CNLM-6193-H-0.1 | L-ASPARAGINE-N-FMOC, N-BETA-TRITYL | 0.1G |
| CNLM-6193-H-MG-PK | L-Asparagine–Fmoc, -β-trityl (¹³C₄, 99%; ¹⁵N₂, 99%) | - |
| CNLM-6219-CA | 2′-DEOXYADENOSINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 100UMOL |
| CNLM-6219-CA-20 | 2′-DEOXYADENOSINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 20UMOL |
| CNLM-6219-SL-10 | 2′-Deoxyadenosine 5′-triphosphate, lithium salt (U-¹³C₁₀, 98%;U-¹⁵N₅, 98%) CP 90% (in solution) | - |
| CNLM-6219-SL-50 | 2′-Deoxyadenosine 5′-triphosphate, lithium salt (U-¹³C₁₀, 98%;U-¹⁵N₅, 98%) CP 90% (in solution) | - |
| CNLM-6220-SL-10 | 2′-Deoxycytidine 5′-triphosphate, lithium salt (U-¹³C₉, 98%;U-¹⁵N₃, 98%) CP 90% (in solution) | - |
| CNLM-6220-SL-50 | 2′-Deoxycytidine 5′-triphosphate, lithium salt (U-¹³C₉, 98%;U-¹⁵N₃, 98%) CP 90% (in solution) | - |
| CNLM-6221-CA | 2′-DEOXYGUANOSINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 100UMOL |
| CNLM-6221-CA-20 | 2′-DEOXYGUANOSINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 20UMOL |
| CNLM-6221-SL-10 | 2′-Deoxyguanosine 5′-triphosphate, lithium salt (U-¹³C₁₀, 98%;U-¹⁵N₅, 98%) CP 90% (in solution) | - |
| CNLM-6221-SL-50 | 2′-Deoxyguanosine 5′-triphosphate, lithium salt (U-¹³C₁₀, 98%;U-¹⁵N₅, 98%) CP 90% (in solution) | - |
| CNLM-6222-SL-10 | Thymidine 5′-triphosphate, lithium salt (U-¹³C₁₀, 98%; U-¹⁵N₂, 98%) (in solution) CP 95% | - |
| CNLM-6222-SL-50 | Thymidine 5′-triphosphate, lithium salt (U-¹³C₁₀, 98%; U-¹⁵N₂, 98%) (in solution) CP 95% | - |
| CNLM-6245-10 | GLUTATHIONE (PEPTIDE PURITY 85-90%) (GLYCINE- | 10MG |
| CNLM-6245-50 | GLUTATHIONE (PEPTIDE PURITY 85-90%) | 50MG |
| CNLM-6245-HP-10 | GLUTATHIONE (PEPTIDE PURITY 95%+) (GLYCINE- | 10MG |
| CNLM-6245-HP-PK | Glutathione (GSH) (glycine-¹³C₂, 98%; ¹⁵N, 96%) (90% net peptide) peptide purity 95% | - |
| CNLM-6696-1 | “CELL FREE” AMINO ACID MIX (20 AA) | 1G |
| CNLM-6792-1.2 | GLYPHOSATE | 1.2ML |
| CNLM-6792-10 | Glyphosate (¹³C₃, 99%; ¹⁵N, 98%) 100 µg/mL in water | - |
| CNLM-6792-PK | Glyphosate (¹³C₃, 99%; ¹⁵N, 98%) | - |
| CNLM-6824-MG-PK | Thymidine phosphoramidite (¹³C₁₀, 98%; ¹⁵N₂, 98%) CP 95% | - |
| CNLM-6825-10 | 2′-DEOXYGUANOSINE PHOSPHORAMIDITE | 10MG |
| CNLM-6825-25 | 2′-DEOXYGUANOSINE PHOSPHORAMIDITE | 25MG |
| CNLM-6825-50 | 2′-DEOXYGUANOSINE PHOSPHORAMIDITE | 50MG |
| CNLM-6828-10 | 2′-DEOXYADENOSINE PHOSPHORAMIDITE | 10MG |
| CNLM-6828-25 | 2′-DEOXYADENOSINE PHOSPHORAMIDITE | 25MG |
| CNLM-6828-50 | 2′-DEOXYADENOSINE PHOSPHORAMIDITE | 50MG |
| CNLM-6830-10 | 2′-DEOXYCYTIDINE PHOSPHORAMIDITE | 10MG |
| CNLM-6830-25 | 2′-DEOXYCYTIDINE PHOSPHORAMIDITE | 25MG |
| CNLM-6830-50 | 2′-DEOXYCYTIDINE PHOSPHORAMIDITE | 50MG |
| CNLM-6993-0.25 | L-ALANINE | 0.25G |
| CNLM-7148-1.2 | METHOMYL (97% CP) 100 UG/ML IN METHANOL | 1.2ML |
| CNLM-7221-1.2 | SEMICARBAZIDE HYDROCHLORIDE (SEM) | 1.2ML |
| CNLM-7289-PK | Cyanamide (stabilized with < 0.1% acetic acid) (¹³C, 99%; ¹⁵N₂, 98%) CP 85% | - |
| CNLM-7333-0.1 | GUANIDINE:HBR | 0.1G |
| CNLM-7333-PK | Guanidine·HBr (¹³C, 99%; ¹⁵N₃, 98%) | - |
| CNLM-7503-CA | SET OF 4 2′-RIBONUCLEOSIDE 5′-TRIPHOSPHATES | 4X100UMOL |
| CNLM-7503-CA-4X20 | SET OF 4 2′-RIBONUCLEOSIDE 5′-TRIPHOSPHATES | 4X20UMOL |
| CNLM-7503-CA-4X50 | SET OF 4 2′-RIBONUCLEOSIDE 5′-TRIPHOSPHATES | 4X50UMOL |
| CNLM-7503-SL-4X10 | Set Of 4 2′-ribonucleoside 5′-triphosphates (U-¹³C, 98%;U-¹⁵N, 98%) CP 90% (in solution) | - |
| CNLM-7503-SL-4X50 | Set Of 4 2′-ribonucleoside 5′-triphosphates (U-¹³C, 98%;U-¹⁵N, 98%) CP 90% (in solution) | - |
| CNLM-7513-SL-4X10 | Set Of 4 2′-deoxyribonucleoside 5′-triphosphates (U-¹³C, 98%;U-¹⁵N, 98%) CP 90% in solution) | - |
| CNLM-7513-SL-4X50 | Set Of 4 2′-deoxyribonucleoside 5′-triphosphates (U-¹³C, 98%;U-¹⁵N, 98%) CP 90% (in solution) | - |
| CNLM-7539-1.2 | CIPROFLOXACIN:HCL 100 UG/ML IN METHANOL | 1.2ML |
| CNLM-7578-H-MG-PK | L-Ornithine·HCl (¹³C₅, 99%; ¹⁵N₂, 99%) | - |
| CNLM-7579-MG-PK | L-Cysteine, -acetyl (cysteine-¹³C₃, 97%; ¹⁵N, 97%) CP 95% | - |
| CNLM-758-0.05 | L-HISTIDINE:HCL:H2O (<5% D) | 0.05G |
| CNLM-758-0.1 | L-HISTIDINE:HCL:H2O (<5% D) | 0.1G |
| CNLM-758-0.25 | L-HISTIDINE:HCL:H2O (<5% D) | 0.25G |
| CNLM-759-H-0.05 | L-METHIONINE | 0.05G |
| CNLM-759-H-0.1 | L-METHIONINE | 0.1G |
| CNLM-759-H-0.25 | L-METHIONINE | 0.25G |
| CNLM-7610-PK | L-Tyrosine (2,3-¹³C₂, 99%; ¹⁵N, 98%) | - |
| CNLM-7611-PK | L-Phenylalanine (2,3-¹³C₂, 99%; ¹⁵N, 98%) | - |
| CNLM-7615-0.1 | L-THREONINE-N-FMOC, O-T-BUTYL ETHER | 0.1G |
| CNLM-7633-0.01 | LAMOTRIGINE | 0.01G |
| CNLM-7694-0.01 | VITAMIN B5,CALCIUM SALT:H2O(CALCIUM PANTO- | 0.01G |
| CNLM-7697-0.25 | GLYCINE-N-FMOC | 0.25G |
| CNLM-7698-0.1 | GLYCINE-N-FMOC | 0.1G |
| CNLM-7807-0.25 | L-METHIONINE | 0.25G |
| CNLM-7809-0.25 | L-TYROSINE | 0.25G |
| CNLM-7810-PK | L-Isoleucine (1-¹³C, 99%; ¹⁵N, 98%) | - |
| CNLM-7812-0.25 | L-GLUTAMIC ACID | 0.25G |
| CNLM-7813-PK | L-Glutamine (1-¹³C, 99%; α-¹⁵N, 98%) | - |
| CNLM-7814-0.25 | L-SERINE | 0.25G |
| CNLM-7815-PK | L-Cysteine (1-¹³C, 99%; ¹⁵N, 98%) | - |
| CNLM-7817-0.25 | L-ASPARTIC ACID | 0.25G |
| CNLM-7818-0.25 | L-ASPARAGINE:H2O | 0.25G |
| CNLM-7819-PK | L-Arginine·HCl (1-¹³C, 99%; α-¹⁵N, 98%) | - |
| CNLM-7821-PK | L-Lysine·2HCl (1-¹³C, 99%; α-¹⁵N, 98%) | - |
| CNLM-7822-PK | L-Proline (1-¹³C, 99%; ¹⁵N, 98%) | - |
| CNLM-7871-SL-4X10 | Set of 4 2′-deoxyribonucleoside 5′-monophosphates (U-¹³C, 98%; U-¹⁵N, 98%) (in solution) CP 95% | - |
| CNLM-7889-0.01 | DL-EPINEPHRINE | 0.01G |
| CNLM-7894-0.01 | HYPOXANTHINE | 0.01G |
| CNLM-7963-S | HMX | 1ML |
| CNLM-7987-S | RDX | 1ML |
| CNLM-8110-MG-PK | Tiglylglycine (glycine-¹³C₂, 98%; ¹⁵N, 98%) | - |
| CNLM-8111-MG-PK | 3-Methylcrotonylglycine (glycine-¹³C₂, 98%; ¹⁵N, 98%) | - |
| CNLM-8111-PK | 3-Methylcrotonylglycine (glycine-¹³C₂, 98%; ¹⁵N, 98%) | - |
| CNLM-8150-1.2 | MELAMINE 100 UG/ML IN WATER | 1.2ML |
| CNLM-8150-10X-1.2 | MELAMINE | 1.2ML |
| CNLM-8183-PK | Suberylglycine (glycine-¹³C₂, 98%; ¹⁵N, 98%) | - |